| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -73.22M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, REPL returned +160.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +52.0% |
| 1 year | +160.5% |
| 5 years | -53.5% |
| All-time high | $51.68 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in REPL would be worth today ›No. Replimune Group, Inc. has not paid a dividend in the past 12 months.
Replimune Group, Inc. stock trades on NASDAQ under the ticker symbol REPL.
Replimune Group, Inc. is part of the Healthcare sector.
Replimune Group, Inc. has a market cap of 1.39B USD, based on the latest quote.
Replimune Group, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
